Metraipolis › archive › dc_d194e5b6fa2d

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN… — Europe PMC PMID:42150333

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42150333
DOI
10.1016/j.tranon.2026.102825
License (as archived)
solo-consultazione
Archived
2026-11-01T13:53:02.854Z
SHA-256 of the archived text
a0c3bcac3b404a2d93ddf7e07d1a2991245cc26a7e071494b3890186462113fb
Stable URL of this page
https://metraipolis.com/documento/dc_d194e5b6fa2d

How to cite

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN… — Europe PMC PMID:42150333 — Europe PMC (en), https://europepmc.org/article/MED/42150333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d194e5b6fa2d (Metraipolis archive dc_d194e5b6fa2d, sha256 a0c3bcac3b404a2d93ddf7e07d1a2991245cc26a7e071494b3890186462113fb)
BibTeX
@misc{dcd194e5b6fa2d,
  title = {Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN… — Europe PMC PMID:42150333},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42150333},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d194e5b6fa2d; sha256 a0c3bcac3b404a2d93ddf7e07d1a2991245cc26a7e071494b3890186462113fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42150333. Agents can read the archived copy with the MCP tool read_document.